Home » Topics » BioWorld Science

BioWorld Science
RSS

[225Ac]OTSA-101 confers complete remission in preclinical model of synovial sarcoma

Jan. 14, 2022

HGF mimetic CM-1021 stimulates liver growth in mice

Jan. 14, 2022

Researchers develop a novel murine model of Cockayne syndrome

Jan. 14, 2022

Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19

Jan. 14, 2022

Sage Therapeutics discloses new GABA-A receptor modulators

Jan. 14, 2022

Gilead Sciences synthesizes new HIV antivirals

Jan. 14, 2022

X4 Pharmaceuticals presents new CXCR4 antagonists

Jan. 14, 2022

Medshine Discovery divulges new GTPase KRAS G12C mutant inhibitors

Jan. 14, 2022

Icahn School of Medicine at Mount Sinai patents DYRK1A inhibitors

Jan. 14, 2022

Antibodies against SIRPA and SIRPB1 promote antitumoral effect in preclinical study

Jan. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...